These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 29079574)

  • 1. Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.
    Cevik O; Li D; Baljinnyam E; Manvar D; Pimenta EM; Waris G; Barnes BJ; Kaushik-Basu N
    J Biol Chem; 2017 Dec; 292(52):21676-21689. PubMed ID: 29079574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
    Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
    Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of MicroRNA-373 Represses the Replication of Hepatitis C Virus via Activation of Type 1 Interferon Response by Targeting IRF5.
    Gong W; Guo X; Zhang Y
    Yonsei Med J; 2018 Dec; 59(10):1181-1189. PubMed ID: 30450852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Cell Death Pathways by Hepatitis C Virus Proteins in Huh7.5 Hepatoma Cells.
    Masalova OV; Lesnova EI; Solyev PN; Zakirova NF; Prassolov VS; Kochetkov SN; Ivanov AV; Kushch AA
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis.
    Kwon YC; Sasaki R; Meyer K; Ray R
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.
    Shirasaki T; Honda M; Yamashita T; Nio K; Shimakami T; Shimizu R; Nakasyo S; Murai K; Shirasaki N; Okada H; Sakai Y; Sato T; Suzuki T; Yoshioka K; Kaneko S
    Sci Rep; 2018 Sep; 8(1):13143. PubMed ID: 30177680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma.
    Pereira Tde A; Witek RP; Syn WK; Choi SS; Bradrick S; Karaca GF; Agboola KM; Jung Y; Omenetti A; Moylan CA; Yang L; Fernandez-Zapico ME; Jhaveri R; Shah VH; Pereira FE; Diehl AM
    Lab Invest; 2010 Dec; 90(12):1690-703. PubMed ID: 20697376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
    Kasai D; Adachi T; Deng L; Nagano-Fujii M; Sada K; Ikeda M; Kato N; Ide YH; Shoji I; Hotta H
    J Hepatol; 2009 May; 50(5):883-94. PubMed ID: 19303158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
    Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
    J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.
    Iyer JK; Kalra M; Kaul A; Payton ME; Kaul R
    World J Gastroenterol; 2017 Oct; 23(37):6802-6816. PubMed ID: 29085224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.
    Whitmill A; Kim S; Rojas V; Gulraiz F; Afreen K; Jain M; Singh M; Park IW
    PLoS One; 2018; 13(8):e0202524. PubMed ID: 30138348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chaperone-Mediated Autophagy in the Liver: Good or Bad?
    Dash S; Aydin Y; Moroz K
    Cells; 2019 Oct; 8(11):. PubMed ID: 31652893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusterin contributes to hepatitis C virus-related hepatocellular carcinoma by regulating autophagy.
    Fu N; Du H; Li D; Lu Y; Li W; Wang Y; Kong L; Du J; Zhao S; Ren W; Han F; Wang R; Zhang Y; Nan Y
    Life Sci; 2020 Sep; 256():117911. PubMed ID: 32504756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hepatitis C virus in hepatocellular carcinoma.
    Haruna Y; Hayashi N; Kamada T; Hytiroglou P; Thung SN; Gerber MA
    Cancer; 1994 May; 73(9):2253-8. PubMed ID: 7513244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.